| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer
1 company
Gerber Brianna serves as a Chief Financial Officer at NAGE. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $39K at current prices.
The biggest single holding is NAGE (~$39K) as Chief Financial Officer. Net of sales, the recent Form 4 record there shows accumulation of 5,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 1, 2023 | NAGE Niagen Bioscience, Inc. | Chief Financial Officer | Buy | 5,000 | $1.41 | $7,050.00 | +22.3% | +18.4% | +447.5% |